Baipsyth: China Merchants Securities Co., Ltd.\'s 2024 semi-annual follow-up report on Beijing Baipsis Biotechnology Co., Ltd.
Bepsyth: 301080 Bepsis Investor Relations Management Information 20240830
Bepsyth: Supervisory Board Resolution Announcement
Bepsyth: Special Report on the Deposit and Use of Funds Raised for the Semi-Annual Year 2024
Bepsyth: Announcement of Board Resolutions
Acrobiosystems: Company bylaws (July 2024)
Acrobiosystems: Notice on providing guarantees for employees' rental housing
Acrobiosystems: Announcement of Resolutions of the 7th Meeting of the 2nd Board of Directors
Acrobiosystems: Announcement of Resolutions of the Seventh Meeting of the Second Board of Supervisors
Acrobiosystems: 301080 Baipsyth Investor Relations Management Information 20240429
Bepsyth: 2023 Annual Audit Report
Bepsyth: The Board's Special Opinion on the Independent Director Assessment
Baipsyth: China Merchants Securities Co., Ltd. site inspection report on Beijing Baipsyth Biotechnology Co., Ltd.'s 2023 continuous supervision work
Bepsyth: Announcement of Board Resolutions
Baipsyth: China Merchants Securities Co., Ltd.'s 2023 follow-up report on Beijing Baipsis Biotechnology Co., Ltd.
Baipsyth: Rongcheng Certified Public Accountants Audit Report on the Annual Storage and Use of Funds Raised by Beijing Baipsis Biotechnology Co., Ltd.
Baipsyth: China Merchants Securities Co., Ltd.'s inspection opinion on Beijing Baipsyth Biotechnology Co., Ltd.'s use of some temporarily idle funds raised and own funds for cash management
Bepsyth: 2023 Independent Director Debriefing Report (Liu Feng)
Bepsyth: 2023 Independent Director Debriefing Report (Zhang Yong)
Baipsis: China Merchants Securities Co., Ltd.'s inspection opinion on the 2023 foreign exchange derivatives investment situation of Beijing Baipsis Biotechnology Co., Ltd.
No Data